[go: up one dir, main page]

US20150342865A1 - Cosmetic composition - Google Patents

Cosmetic composition Download PDF

Info

Publication number
US20150342865A1
US20150342865A1 US14/654,558 US201314654558A US2015342865A1 US 20150342865 A1 US20150342865 A1 US 20150342865A1 US 201314654558 A US201314654558 A US 201314654558A US 2015342865 A1 US2015342865 A1 US 2015342865A1
Authority
US
United States
Prior art keywords
composition
acid
weight
fatty acid
silicone resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/654,558
Other languages
English (en)
Inventor
Mingqi AO
Naresh Dhirajlal Ghatlia
Hangsheng Li
Xiuxia Wang
Caigen YUAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conopco Inc
Original Assignee
Conopco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conopco Inc filed Critical Conopco Inc
Assigned to CONOPCO, INC., D/B/A UNILEVER reassignment CONOPCO, INC., D/B/A UNILEVER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WANG, XIUXIA, AO, Mingqi, GHATLIA, NARESH DHIRAJLAL, LI, Hangsheng, YUAN, CAIGEN
Publication of US20150342865A1 publication Critical patent/US20150342865A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/892Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/896Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q90/00Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/591Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/594Mixtures of polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to a cosmetic composition.
  • the composition comprises from 0.01 to 9% of film-forming polymer having a contact angle of at least 85° by weight of the composition, from 0.01 to 3.5% of fatty compound by weight of the composition and optical particle, wherein the fatty compound is selected from fatty acid, soap, or a mixture thereof.
  • composition comprising film-forming polymer may be one solution for consumers to these problems.
  • Film-forming polymer would form a film onto the skin after applying topically and bring immediate firming effect to the skin.
  • Some beneficial agents for example optical particle and sunscreen agent, may also be delivered onto skin surface together with the film-forming polymer.
  • US patent application with publication number of US 2008/0233075 A1 disclosed a topical composition
  • a topical composition comprising a water-soluble film-forming polymer, a bimodal copolymer comprising a first polymeric component with anionic functional groups and a second polymeric component with cationic functional groups, and one or more biological polymers that are derived from a source selected from the group consisting of animals, plants, algae, fungi, and bacteria or are biotechnologically synthesized.
  • Such a topical composition was said to be applied to saggy or wrinkled skin for enhancing the appearance of the skin.
  • the skin may undergo water washing and abrasion by hand and therefore the film formed by film-forming polymer on the skin may be easily washed away and/or rubbed away and therefore lose the benefits.
  • the beneficial agent would be easily washed off and/or rubbed off and thus can not provide a long-lasting benefit.
  • this invention is directed to a cosmetic composition
  • a cosmetic composition comprising from 0.01 to 9% of film-forming polymer having a contact angle of at least 85° by weight of the composition, from 0.01 to 3.5% of fatty compound by weight of the composition and optical particle, wherein the fatty compound is selected from fatty acid, soap, or a mixture thereof.
  • the present invention is directed to a cosmetic composition
  • a cosmetic composition comprising from 0.01 to 9% of film-forming polymer having a contact angle of at least 85° by weight of the composition, from 0.01 to 3.5% of fatty compound by weight of the composition and optical particle, wherein the fatty compound is selected from fatty acid, soap, or a mixture thereof.
  • the present invention is directed to a method for improving skin characteristic comprising the step of topically applying to skin any embodiment of the first aspect.
  • the present invention is directed to use of any embodiment of the first aspect for improving any attribute selected from opacity, long-lasting opacity, cumulative deposition of optical particle, wash-off resistance, abrasion resistance, or combination thereof.
  • Frm-forming polymer refers to polymer which is capable of forming cohesive and continuous covering over the hair and/or skin when applied to their surface.
  • Silicone resin refers to silicone material which is formed by branched, and/or cage-like oligosiloxanes having three-dimensional structure. Typically, the silicone resin is rigid.
  • “Fatty compound” refers organic compound having a straight-chain with length of at least 8 carbon atoms, preferably at least 10 carbon atoms. More preferably, the fatty compound has a C 10 to C 36 straight-chain, even more preferably a C 12 to C 28 straight-chain.
  • Contact angle means the angle at which a water/vapor interface meets a solid surface at a temperature of 25° C. Such an angle may be measured with a goniometer or other water droplet shape analysis systems with water droplet of 5 ⁇ l and at 25° C.
  • Melting point is the temperature at which it changes state from solid to liquid at atmospheric pressure.
  • the melting point of fatty compound may be measured for example by method in standard of ISO 6321-2002.
  • Optical particle refers to particle which can impart opacity to skin. Opacity as used herein will also include masking/reducing blemishes, even skin tone and/or skin lightening. “Refractive index values” referred to herein are those determined at a temperature of 25° C. and a wavelength of 589 nm unless otherwise stated.
  • “Leave-on” as used with reference to compositions herein means a composition that is applied to or rubbed on the skin, and left thereon.
  • “Wash-off” as used with reference to compositions herein means a skin cleanser that is applied to or rubbed on the skin and rinsed off substantially immediately subsequent to application.
  • “Skin” as used herein includes the skin on the face (except eye lids and lips), neck, chest, abdomen, back, arms, underarm area, hands, and legs.
  • skin means skin on the face except eye lids and lips. More preferably, “skin” means skin on cheeks.
  • the composition is neither a cosmetic composition comprising silicone resin, non-volatile silicone oil, and cosmetically acceptable carrier, wherein the non-volatile silicone oil comprises dimethiconol, aminosilicone or a mixture thereof and the weight ratio of the silicone resin to the non-volatile silicone oil is at least 1:4; nor a cosmetic composition comprising a silicone resin, a steroid, and cosmetically acceptable carrier, wherein the weight ratio of silicone resin to steroid is at least 5:9.
  • the requirement for film-forming polymer of the present invention is that the film-forming polymer is suitable for use in cosmetic composition.
  • the film-forming polymer preferably has a contact angle of at least 90°, more preferably from 95° to 160°, most preferably from 100° to 120°.
  • the film-forming polymer may for example comprise silicone resin, chitosan, or a mixture thereof. More preferably, the film-forming polymer comprises silicone resin and most preferably the film-forming polymer is silicone resin.
  • the silicone resin is typically described by the following siloxy monomeric units:
  • the R group may be selected from saturated or unsaturated hydrocarbon groups.
  • the silicone resin of the present invention may be selected from siloxysilicate, silsesquioxane, or a mixture thereof. More preferably, the silicone resin comprises M unit, Q unit, T unit or combination thereof. Even more preferably, the silicone resin comprises MQ silicone resin, T silicone resin, or a mixture thereof.
  • the silicone resin preferably comprises MQ silicone resin having the formula of [(R 1 ) 3 —Si—O 1/2 ] a —(Si—O 4/2 ) b , wherein R 1 is mutually identical or different, selected from saturated hydrocarbon groups.
  • R 1 is preferably selected from C 1 to C 6 alkyl, and more preferably each R 1 is methyl group.
  • the more preferred MQ silicone resin is trimethylsiloxysilicate.
  • a and b independently have values ranging from 10 to 1000, and more preferably from 30 to 200.
  • the silicone resin preferably comprises T silicone resin having the formula of [R 2 —Si—O 3/2 ] x , wherein R 2 is selected from saturated hydrocarbon groups.
  • R 2 is preferably selected from C 1 to C 6 alkyl, more preferably selected from methyl, ethyl, propyl, butyl, and most preferably propyl.
  • the most preferred T silicone resin is polypropyl silsesquioxane.
  • x is less than 2000, more preferably less than 500, but preferably greater than 10, and more preferably greater than 50.
  • the silicone resin preferably comprises a blend of MQ silicone resin and T silicone resin, the weight ratio of the MQ silicone resin to the T silicone resin is preferably from 1:20 to 20:1 in order to achieve better film-forming performance. More preferably, the weight ratio of the MQ silicone resin to the T silicone resin is from 1:10 to 10:1, even more preferably from 1:5 to 5:1.
  • Exemplary silicone resin suitable for the present invention includes Dow CorningTM MQ-1640 Flake Resin, a blend of MQ and T Propyl resins, Dow CorningTM MQ-1600 Solid Resin, a 100% active MQ resin, Dow CorningTM 670 Fluid, Cyclopentasiloxane (and) Polypropylsilsesquioxane supplied by Dow Corning.
  • the film-forming polymer is present in the composition in amount of from 0.05 to 8% by weight of the composition, more preferably from 0.3 to 7%, even more preferably from 0.8 to 5%, and most preferably from 1 to 4% by weight of the composition.
  • the fatty acid typically contains fatty acid mdeties with chain lengths of from C10 to C30.
  • the hydrocarbon chain length of the fatty acid used is from 12 to 24, more preferably 14 to 20, even more preferably 16 to 18 carbon atoms.
  • Suitable fatty acid comprises pelargonic, lauric, myristic, palmitic, isopalmitic, stearic, isostearic, oleic, linoleic, ricinoleic, arachiolic, behenic, erucic acid or a mixture thereof. More preferably, the fatty acid comprises stearic, lauric, palmitic, isostearic, myristic acid, or a mixture thereof. Even more preferably, the fatty acid is stearic acid, palmitic acid or a mixture thereof.
  • suitable fatty acid may contain unsaturated fatty acid moieties, and may contain fatty acid moieties having a degree of substitution, such as e.g. hydroxy fatty acids. It is preferred that the fatty acid comprises saturated fatty acid, saturated fatty acid having a degree of substitution, or a combination thereof. More preferably, the fatty acid comprises saturated is selected from saturated fatty acid, saturated fatty acid having a degree of substitution, or a combination thereof. Even more preferably, the fatty acid is saturated fatty acid.
  • Soap of the present invention is preferably a salt of a C 10 -C 30 fatty acid, more preferably C 12 -C 24 fatty acid, even more preferably C 14 -C 20 fatty acid and most preferably C 16 -C 18 fatty acid.
  • Suitable soap comprises pelargonate, laurate, myristate, palmitate, stearate, isostearate, oleate, linoleate, ricinoleate, arachidate, behenate, erucate salt or a mixture thereof.
  • the fatty acid salt comprises stearate, laurate, palmitate, isostearate salt or a mixture thereof.
  • the fatty acid salt is stearate salt, palmitate salt or a mixture thereof.
  • the soap is selected from ammonium salt, alkali metal salt or mixture thereof. More preferably, the soap is sodium and/or potassium salt, and most preferably sodium salt.
  • the fatty compound comprises fatty acid and soap, it is preferred the fatty compound comprises fatty acid and salt thereof. More preferably the fatty compound is a combination of fatty acid and salt thereof.
  • the fatty compound is preferably present in the composition in amount of from 0.01 to 3.3% by weight of the composition, more preferably from 0.7 to 3%, even more preferably from 1.5 to 2.5% by weight of the composition.
  • the weight ratio of film-forming polymer to fatty compound is preferably from 50:1 to 1:10, more preferably from 10:1 to 1:2, even more preferably from 5:1 to 1:1, and most preferably from 4:1 to 2:1.
  • the cosmetic composition also comprises optical particle.
  • optical particles would be embedded into the film by film-forming polymer and fatty compound. Therefore, the optical particles are able to resist water and/or friction and deliver the long-lasting opacity to the skin.
  • the optical particles are typically particles of high refractive index materials.
  • the optical particles may have a refractive index of greater than 1.3, more preferably greater than 1.7 and most preferably from 2.0 to 2.7.
  • Examples of such optical particles are those comprising bismuth oxy-chloride, boron nitride, barium sulfate, mica, silica, titanium dioxide, zirconium oxide, iron oxide, aluminium oxide, zinc oxide or combinations thereof. More preferred particles are particles comprising titanium dioxide, zinc oxide, zirconium oxide, mica, iron oxide or a combination thereof. Even more preferred particles are particles comprising zinc oxide, zirconium oxide, titanium dioxide or a combination thereof as these materials have especially high refractive index. Most preferred is titanium dioxide.
  • the optical particle is preferably hydrophobic. More preferably, the optical particle is preferably hydrophobically modified. Even more preferably the optical particle is modified by hydrophobic material selected from fatty acid, silicone oil, wax, and a mixture thereof.
  • the fatty acid preferably comprises oleic acid, stearic acid, or a mixture thereof.
  • the size of optical particle is typical from 2 nm to 5 microns, more preferably from 5 nm to 1 micron, even more preferably from 10 nm to 500 nm.
  • Particle size as used herein refers to the diameter of particles in an unaggregated state. Diameter means the largest measureable distance on a particle in the event a well-defined sphere is not generated. The diameter may be measured for example by scanning electron microscopy (SEM) by averaging the value of at least ten particles.
  • SEM scanning electron microscopy
  • the composition comprises optical particles in an amount of from 0.001 to 10 wt %, more preferably 0.01 to 7 wt %, more preferably still 0.05 to 5 wt % and most preferably 0.1 to 2 wt %.
  • the weight ratio of the film-forming polymer to the optical particle is preferably in the range of from 1:10 to 50:1, more preferably from 1:3 to 10:1, and most preferably from 1:1 to 5:1.
  • the weight ratio of the fatty compound to the optical particle is preferably in the range of from 1:40 to 20:1, more preferably from 1:20 to 10:1, and most preferably from 1:10 to 5:1.
  • compositions of the present invention may also include at least 20% of water by weight of the composition.
  • the amounts of water is at least 40%, more preferably range from more preferably from 50 to 90%, optimally between 60 and 85% by weight of the composition.
  • the weight ratio of water to wax is from 1:1 to 1000:1, more preferably from 5:1 to 200:1, and most preferably from 15:1 to 60:1.
  • Emollient materials may be included as carriers in compositions of this invention. These may be in the form of silicone oils, synthetic esters and/or hydrocarbons. Amounts of the emollients may range, for example, anywhere from 0.1 to 95%, more preferably between 1 and 50% by weight of the composition.
  • Silicone oils may be divided into the volatile and nonvolatile variety.
  • volatile refers to those materials which have a measurable vapor pressure at ambient temperature (25° C.).
  • Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
  • the volatile silicone oils may form a relatively large component of the compositions as carriers. Amounts may range, for example, from 5% to 80%, more preferably from 20% to 70% by weight of the composition.
  • Nonvolatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers.
  • the essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 ⁇ 10 ⁇ 8 to 0.1 m 2 /s at 25° C.
  • the preferred nonvolatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1 ⁇ 10 ⁇ 5 to about 4 ⁇ 10 ⁇ 4 m 2 /s at 25° C.
  • Organopolysiloxane crosspolymers can be usefully employed. Representative of these materials are dimethicone/vinyl dimethicone crosspolymers and dimethicone crosspolymers available from a variety of suppliers including Dow Corning (9040, 9041, 9045, 9506 and 9509), General Electric (SFE 839), Shin Etsu (KSG-15, 16 and 18 [dimethicone/phenyl vinyl dimethicone crosspolymer]), and Grant Industries (Gransil brand of materials), and lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu (e.g.
  • Amounts of the aforementioned organopolysiloxane crosspolymers (when present) will usually be from 0.1 to 20% by weight dissdved usually in a volatile silicone oil such as cyclomethicone.
  • silicones When silicones are present in large amounts as carrier and water is also present, the systems may be oil continuous. These normally will require emulsification with a water-in-oil emulsifier such as a dimethicone copolyol (e.g. Abil EM-90 which is cetyl dimethicone copolyol).
  • a water-in-oil emulsifier such as a dimethicone copolyol (e.g. Abil EM-90 which is cetyl dimethicone copolyol).
  • ester emollients are:
  • Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C 11 -C 13 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
  • Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers.
  • Typical polyhydric alcohols include polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, glycerol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof.
  • the amount of humectant may range, for example, anywhere from 0.5 to 50%, more preferably between 1 and 15% by weight of the composition. Most preferred is glycerol (also known as glycerin). Amounts of glycerin may range, for example, from 1% to 50%, more preferably from 10 to 35%, optimally from 15 to 30% by weight of the composition.
  • compositions of this invention may include a variety of other functional ingredients.
  • Sunscreen actives may be included in compositions of the present invention. These will be organic compounds having at least one chromophoric group absorbing within the ultraviolet ranging from 290 to 400 nm.
  • Chromophoric organic sunscreen agents may be divided into the following categories (with specific examples) including: p-Aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid); Anthranilates (o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); Salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters); Cinnamic acid derivatives (menthyl and benzyl esters, alpha-phenyl cinnamonitrile; butyl cinnamoyl pyruvate); Dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone,
  • 2-ethylhexyl p-methoxycinnamate 4,4′-t-butyl methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoic acid, oligalloyltrioleate, 2,2-dihydroxy-4-methoxybenzophenone, ethyl 4-[bis(hydroxypropyl)]aminobenzoate, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, 2-ethylhexylsalicylate, glyceryl p-aminobenzoate, 3,3,5-trimethylcyclohexylsalicylate, methylanthranilate, p-dimethylaminobenzoic acid or aminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, 2-phenylbenzimidazo
  • ethylhexyl p-methoxycinnamate available as Parsol MCX®
  • Avobenzone available as Parsol 1789®
  • Dermablock OS® octylsalicylate
  • Mexoryl SX® with INCI name of Terephthalylidene Dicamphor Sulfonic Acid
  • Amounts of the organic sunscreen agent may range, for example, from 0.1 to 15%, more preferably from 0.5% to 10%, optimally from 1% to 8% by weight of the composition.
  • thickening agents may be included in the compositions. Illustrative but not limiting are stearic acid, Acrylamide/Sodium Acryloyldimethyltaurate Copolymer (Aristoflex AVC), Hydroxyethyl Acrylate/Sodium Acryloyldimethyltaurate Copolymer, Aluminum Starch Octenyl Succinate, Polyacrylates (such as Carbomers including Carbopol® 980, Carbopol® 1342, Pemulen TR-2® and the Ultrez® thickeners), Polysaccharides (including xanthan gum, guar gum, pectin, carageenan and sclerotium gums), celluloses (including carboxymethyl cellulose, ethyl cellulose, hydroxyethyl cellulose and methyl hydroxymethyl cellulose), minerals (including talc, silica, alumina, mica and clays, the latter being represented by bentonites, hectorites and attapulgites), magnesium aluminum silicate and
  • Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms.
  • Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid.
  • Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds.
  • Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability.
  • preservatives are phenoxyethanol, methyl paraben, propyl paraben, butyl paraben, isobutyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol.
  • the preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the composition.
  • Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
  • compositions of the present invention may also contain vitamins and flavondds.
  • Illustrative water-soluble vitamins are Niacinamide, Vitamin B 2 , Vitamin B 6 , Vitamin C, ascorbyl phosphate and Biotin.
  • useful water-insoluble vitamins are Vitamin A (retinol), Vitamin A Palmitate, ascorbyl tetraisopalmitate, Vitamin E (tocopherol), Vitamin E Acetate and L-panthenol.
  • a particularly suitable Vitamin B 6 derivative is Pyridoxine Palmitate.
  • the preferred flavonoids are glucosyl hesperidin and rutin.
  • Total amount of vitamins or flavonoids when present in compositions according to the present invention may range, for example, from 0.001 to 10%, more preferably from 0.01% to 5%, optimally from 0.1 to 3% by weight of the composition.
  • Desquamation agents are further optional components.
  • Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids and salts of these acids.
  • the former are salts of glycolic acid, lactic acid and malic acid.
  • Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from 0.1 to 15% by weight of the composition.
  • compositions of this invention may optionally be included in compositions of this invention.
  • Illustrative are pomegranate, white birch ( Betula Alba ), green tea, chamomile, licorice, boswellia serrata, olive ( Olea Europaea ) leaf, arnica montana flower, lavandula angustifolia, and extract combinations thereof.
  • the extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.
  • Miscellaneous other adjunct cosmetic ingredients that may be suitable for the present compositions include ceramides (e.g. Ceramide 3 and Ceramide 6), conjugated linoleic acids, colorants (e.g. iron oxides), metal (manganese, copper and/or zinc) gluconates, allantoin, palmitoyl pentapeptide-3, amino acids (e.g. alanine, arginine, glycine, lysine, proline, serine, threonine, glumatic acid and mixtures thereof), trimethylglycine, sodium PCA, chelator like disodium EDTA, magnesium aspartate, and combinations thereof.
  • Amounts may, for example, vary from 0.000001 to 3% by weight of the composition.
  • a small amount of emulsifying surfactant may be present.
  • Surfactants may be anionic, nonionic, cationic, amphoteric and mixtures thereof. Levels may range, for example, from 0.1 to 5%, more preferably from 0.1 to 2%, optimally from 0.1 to 1% by weight.
  • the amount of surfactant present should not be sufficient for lather formation. In these instances, less than 2% by weight, preferably less than 1%, and optimally less than 0.5% by weight surfactant is present.
  • Emulsifiers like PEG-100 stearate may be used as well as emulsion stabilizers like cetearyl alcohol and ceteareth-20 may be used and typically in amounts that do not exceed 5 percent by weight of the composition.
  • cationic ammonium compounds to enhance moisturization.
  • Such compounds include salts of hydroxypropyltri (C 1 -C 3 alkyl) ammonium mono-substituted-saccharide, salts of hydroxypropyltri (C 1 -C 3 alkyl) ammonium mono-substituted polyols, dihydroxypropyltri (C 1 -C 3 alkyl) ammonium salts, dihydroxypropyldi (C 1 -C 3 alkyl) mono(hydroxyethyl) ammonium salts, guar hydroxypropyl trimonium salts, 2,3-dihydroxypropyl tri(C 1 -C3 alkyl or hydroxalkyl) ammonium salts or mixtures thereof.
  • the cationic ammonium compound employed in this invention is the quaternary ammonium compound 1,2-dihydroxypropyltrimonium chloride. If used, such compounds typically make up from 0.01 to 30%, and more preferably from about 0.1 to about 15% by weight of the composition.
  • moisturizing agents such as substituted ureas like hydroxymethyl urea, hydroxyethyl urea, hydroxypropyl urea; bis(hydroxymethyl)urea; bis(hydroxyethyl)urea; bis(hydroxypropyl)urea; N,N′-dihydroxymethyl urea; N,N′-di-hydroxyethyl urea; N,N′-di-hydroxypropyl urea; N,N,N′-tri-hydroxyethyl urea; tetra(hydroxymethyl)urea; tetra(hydroxyethyl)urea; tetra(hydroxypropyl)urea; N-methyl-N′-hydroxyethyl urea; N-ethyl-N′-hydroxyethyl urea; N-hydroxypropyl-N′-hydroxyethyl urea and N,N′dimethyl-N-hydroxy
  • hydroxypropyl appears, the meaning is generic for either 3-hydroxy-n-propyl, 2-hydroxy-n-propyl, 3-hydroxy-i-propyl or 2-hydroxy-i-propyl radicals. Most preferred is hydroxyethyl urea. The latter is available as a 50% aqueous liquid from AkzoNobel under the trademark Hydrovance. Such substituted ureas, while desirable in moisturizing formulations, are only selected for use when compatible with sunless tanning agent or agents (when used) in the compositions of this invention.
  • Amounts of substituted urea, when used, in the composition of this invention range from 0.01 to 20%, more preferably from 0.5 to 15%, and most preferably from 2 to 10% based on total weight of the composition and including all ranges subsumed therein.
  • cationic ammonium compound and substituted urea in a most especially preferred embodiment at least from 0.01 to 25%, more preferably from 0.2 to 20%, and most preferably from 1 to 15% humectant, like glycerine, is used, based on total weight of the composition and including all ranges subsumed therein.
  • ingredients are typically mixed with moderate shear under atmospheric conditions.
  • the compositions may be applied topically and preferably 1-4 milligrams of composition is applied per square centimeter of skin.
  • the compositions display a pH from 5 to 7.
  • Packaging for the composition of this invention can be a jar or tube as well as any other format typically seen for cosmetic, cream, washing and lotion type products.
  • composition is a skin care composition.
  • the composition may be a leave-on composition or a wash-off composition, but preferably a leave-on composition.
  • the invention also concerns a method for improving skin characteristic comprising the step of topically applying to skin the cosmetic composition of the invention as described.
  • Skin characteristic refers to features used to evaluate skin, include but not limit to skin firming, opacity, smoothness, cleanliness, moistening, or a combination thereof.
  • the skin characteristics comprise skin firming, opacity, or a combination thereof. More preferably the skin characteristic is long-lasting opacity and most preferably, the skin characteristic is long-lasting whitening.
  • “Long-lasting” refers to the beneficial agent (for example optical particle) remains at least 30%, preferably at least 50% after flushing by tap water (25° C.) for 1 minute.
  • the base formulation (sample A in Table 1) was coated evenly onto Bio-skin plate (Color: 30#, ex. BEAULAX, Co. Ltd., Tokyo, Japan) with surface density of 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, and 6 mg/cm 2 .
  • the L (for lightness), a, and b (for the color-opponent dimensions) of these coated Bio-skin plates was measured using Digieye Imaging System (Verivide, UK).
  • the ITA value versus surface density was plotted and fitted by a polynomial model to obtain the curve.
  • the R-Square was higher than 0.999 which demonstrated that the polynomial model was suitable to fit the functional relationship between the lightness and the surface density of the base formulation.
  • the L, a, and b of the Bio-skin plate were measured again by Digieye Imaging System and the ITA value of the Bio-skin plate (ITA 2 ) was calculated.
  • the surface density after wash-off/abrasion experiment (SD 2 ) was obtained according to the calibration curve.
  • Deposition ratio ( SD 2 /SD 1 ) ⁇ 100%.
  • the contact angles of Dow CorningTM MQ-1640 Flake Resin, Dow CorningTM MQ-1600 Solid Resin, Dow CorningTM 670, AvalureTM UR450, and LexorezTM 100 were 107°, 116°, 114°, 66°, and 28° respectively.
  • the formulations were prepared by the following process.
  • the optical particles were completely dispersed in the oil phase with other ingredients and the silicone resin and/or fatty compound (when present) mixed thoroughly.
  • the resulting oil-based mixture was gradually added to the aqueous phase.
  • the resulting mixture was emulsified under 9,000 rpm of shear stress for 10 minutes at 65° C. and gradually stirred and cooled to room temperature.
  • the deposition ratios of the samples were measured by following the Wash-off/abrasion resistance performance test.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
US14/654,558 2012-12-24 2013-12-18 Cosmetic composition Abandoned US20150342865A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN2012087267 2012-12-24
CNPCT/CN2012/087301 2012-12-24
CNPCT/CN2012/087267 2012-12-24
CN2012087301 2012-12-24
EP13153662 2013-02-01
EP13153664.1 2013-02-01
EP13153664 2013-02-01
EP13153662.5 2013-02-01
PCT/CN2013/089863 WO2014101701A1 (en) 2012-12-24 2013-12-18 Cosmetic composition

Publications (1)

Publication Number Publication Date
US20150342865A1 true US20150342865A1 (en) 2015-12-03

Family

ID=51019871

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/654,564 Active US9585831B2 (en) 2012-12-24 2013-12-18 Cosmetic composition
US14/654,554 Active US10449138B2 (en) 2012-12-24 2013-12-18 Cosmetic composition
US14/654,558 Abandoned US20150342865A1 (en) 2012-12-24 2013-12-18 Cosmetic composition

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US14/654,564 Active US9585831B2 (en) 2012-12-24 2013-12-18 Cosmetic composition
US14/654,554 Active US10449138B2 (en) 2012-12-24 2013-12-18 Cosmetic composition

Country Status (8)

Country Link
US (3) US9585831B2 (es)
EP (4) EP2934435B1 (es)
JP (3) JP6506696B2 (es)
BR (2) BR112015014497A2 (es)
CA (3) CA2892740C (es)
MX (3) MX367561B (es)
WO (4) WO2014101702A1 (es)
ZA (3) ZA201504119B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11737958B2 (en) 2017-04-18 2023-08-29 Kao Corporation Method for producing UV protective coating

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585831B2 (en) * 2012-12-24 2017-03-07 Conopco, Inc. Cosmetic composition
CN107072930A (zh) * 2014-09-02 2017-08-18 Edgewell个人护理品牌有限责任公司 矿物防晒剂组合物
MX389713B (es) 2016-01-22 2025-03-20 Edgewell Personal Care Brands Llc Composiciones topicas hidrofobas.
BR112019021763A2 (pt) * 2017-04-18 2020-05-05 Kao Corp método para a produção de revestimento cosmético
CN110520100A (zh) * 2017-04-18 2019-11-29 花王株式会社 紫外线防御覆膜的制造方法
EP3613411A4 (en) * 2017-04-18 2020-12-30 Kao Corporation COATING PRODUCTION PROCESS
JP7216485B2 (ja) * 2017-04-18 2023-02-01 花王株式会社 化粧被膜の製造方法
CN110545786A (zh) * 2017-04-19 2019-12-06 花王株式会社 覆膜的制造方法
FR3075632B1 (fr) * 2017-12-22 2020-03-06 L'oreal Composition sous forme d’une emulsion comprenant une resine siliconee, une huile siliconee aminee et procede la mettant en oeuvre
WO2020078728A1 (en) 2018-10-15 2020-04-23 Unilever N.V. A cosmetic composition
MX2023001095A (es) * 2020-07-29 2023-03-01 Unilever Ip Holdings B V Mascarilla cosmetica para mejorar la apariencia de la piel.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074652A (en) * 1996-05-20 2000-06-13 Shiseido Co., Ltd. Oil-in-water emulsified composition and oil-in-water emulsifying agent
US20120121673A1 (en) * 2009-05-04 2012-05-17 Milanka Susak Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound
US20130295028A1 (en) * 2012-05-03 2013-11-07 Wilson A. Lee Emulsified MQ Resin: Compositions And Methods
US20140213750A1 (en) * 2011-09-07 2014-07-31 Dow Corning Corporation Hafnium Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615448B2 (ja) 1984-09-06 1994-03-02 株式会社資生堂 皮膚化粧料
JP2539190B2 (ja) 1985-01-11 1996-10-02 株式会社資生堂 皮膚化粧料
JPS62298519A (ja) 1986-06-19 1987-12-25 Shiseido Co Ltd 皮膚化粧料
US5013763A (en) 1987-11-30 1991-05-07 The Andrew Jergens Company Wash-off-resistant skin preparation
JP2657504B2 (ja) 1988-01-12 1997-09-24 株式会社資生堂 油中水型乳化組成物
US5599547A (en) * 1994-11-22 1997-02-04 The Procter & Gamble Company Mascara compositions
JP3513862B2 (ja) 1994-11-30 2004-03-31 株式会社コーセー 油性固形化粧料
JP3269824B2 (ja) 1995-02-15 2002-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー ストレス安定性泡立ち性皮膚クレンジングリキッド組成物及び個人用バス及びボディクレンジングキット
JPH08268856A (ja) 1995-03-31 1996-10-15 Shiseido Co Ltd 日焼け止め化粧料
JP3468971B2 (ja) 1995-07-05 2003-11-25 カネボウ株式会社 化粧料
FR2739281B1 (fr) 1995-09-29 1997-10-31 Oreal Composition topique contenant un polymere greffe silicone et une silicone aminee et/ou une gomme ou une resine siliconee
US5772696A (en) 1995-12-13 1998-06-30 Warner-Jenkinson Company, Inc. Process for purification of water soluble dyes via water insoluble metal salt intermediate
JPH1043342A (ja) 1996-05-01 1998-02-17 Bridgestone Sports Co Ltd 練習用ゴルフボール
JPH09309818A (ja) 1996-05-22 1997-12-02 Noevir Co Ltd 乳化型日焼け止め化粧料
JPH107517A (ja) 1996-06-16 1998-01-13 Shiseido Co Ltd 化粧料
JPH109714A (ja) 1996-06-25 1998-01-16 Hitachi Ltd 冷凍装置
JPH1161097A (ja) 1997-08-28 1999-03-05 Nissan Chem Ind Ltd 紫外線吸収剤
JPH1180237A (ja) 1997-09-10 1999-03-26 Tonen Corp α−オレフィン重合用触媒
JP3778324B2 (ja) * 1998-03-30 2006-05-24 株式会社資生堂 水中油型乳化組成物
JP3535389B2 (ja) * 1998-07-31 2004-06-07 株式会社資生堂 外用組成物
JP2000072645A (ja) 1998-08-27 2000-03-07 Kose Corp 油中水型乳化化粧料
JP2000119165A (ja) 1998-10-16 2000-04-25 Kanebo Ltd 乳化型皮膚外用剤
US6036967A (en) 1998-10-28 2000-03-14 Archimica (Florida), Inc. Mixtures of trimethylsilylated silicas and alkylsiloxanes
US6309657B2 (en) * 1999-02-12 2001-10-30 The Procter & Gamble Company Cosmetic compositions
MXPA02002608A (es) 1999-09-09 2003-10-14 Johnson & Johnson Res Pty Ltd Crema hidratante para la estabilidad de la piel.
JP2002201109A (ja) 2000-12-28 2002-07-16 Lion Corp シート状化粧料
DE10136883B4 (de) 2001-07-24 2008-08-21 Coty B.V. Wasser- und abriebfestes Kosmetikum für Haare und dekorative Kosmetik
US20030082129A1 (en) 2001-08-07 2003-05-01 Buckingham Anne Marie Hair and skin care compositions containing siloxane-based polyamide copolymers
WO2003026596A1 (en) * 2001-09-26 2003-04-03 The Procter & Gamble Company Topical compositions containing solid particulates and a silicone resin copolymer fluid
JP3727901B2 (ja) * 2001-09-27 2005-12-21 株式会社コーセー 水中油型乳化化粧料
JP2003171223A (ja) 2001-12-10 2003-06-17 Pola Chem Ind Inc なめらかさを付与する化粧料
JP2003183119A (ja) 2001-12-21 2003-07-03 Pola Chem Ind Inc なめらかさを付与する化粧料
US20030235552A1 (en) 2002-06-12 2003-12-25 L'oreal Cosmetic composition for care and/or makeup, structured with silicone polymers and film-forming silicone resins
US20030232030A1 (en) 2002-06-12 2003-12-18 L'oreal Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same
JP2004059476A (ja) 2002-07-26 2004-02-26 Kose Corp 油中水型化粧料
JP2004115479A (ja) 2002-09-30 2004-04-15 Pola Chem Ind Inc ムクミ改善用のマッサージ化粧料
JP2004203788A (ja) * 2002-12-25 2004-07-22 Kose Corp 固形状油中水型乳化化粧料
JP2004262851A (ja) 2003-03-03 2004-09-24 Kanebo Ltd 化粧料
JP2005053796A (ja) 2003-08-04 2005-03-03 Shiseido Co Ltd メークアップ皮膚化粧料
JP4491216B2 (ja) 2003-10-07 2010-06-30 株式会社コーセー 水中油型睫用化粧料
US20050089498A1 (en) 2003-10-24 2005-04-28 Patil Anjali A. Cosmetic compositions containing first and second film forming polymers
JP4084294B2 (ja) 2003-12-11 2008-04-30 花王株式会社 油中水型睫用化粧料
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20050142079A1 (en) 2003-12-26 2005-06-30 Garrison Mark S. Oil in silicone emulsion and compositions containing same
WO2005075567A1 (en) 2004-02-02 2005-08-18 Dow Corning Corporation Mq and t-propyl siloxane resins compositions
JP2005263699A (ja) 2004-03-19 2005-09-29 Kanebo Cosmetics Inc 睫用化粧料
US7666824B2 (en) 2004-04-22 2010-02-23 Kimberly-Clark Worldwide, Inc. Liquid cleanser compositions
JP4717537B2 (ja) 2004-08-31 2011-07-06 株式会社 資生堂 皮膚外用組成物
US20060078578A1 (en) 2004-10-07 2006-04-13 Sandewicz Robert W Cosmetic compositions with montmorillonite stabilizing agent
US20060110346A1 (en) * 2004-11-04 2006-05-25 L'oreal Transfer-resistant cosmetic compositions
US20060127333A1 (en) * 2004-12-13 2006-06-15 Patil Anjali A Cosmetic compositions containing very high viscosity silicone gum
JP2006225347A (ja) 2005-02-18 2006-08-31 Shiseido Co Ltd 皮膚外用組成物
JP2006282517A (ja) 2005-03-31 2006-10-19 Kose Corp ゲル組成物及びそれを含有する化粧料
DE102005019953A1 (de) 2005-04-28 2006-11-02 Beiersdorf Ag Transferresistente Lippenpflegeprodukte
US8025869B2 (en) 2005-06-28 2011-09-27 L'oréal Cosmetic compositions having enhanced wear properties
JP4815166B2 (ja) 2005-08-24 2011-11-16 日本精化株式会社 油性基剤及びこれを含有する化粧料及び皮膚外用剤
JP4993983B2 (ja) * 2005-09-28 2012-08-08 信越化学工業株式会社 オルガノポリシロキサン表面処理剤系及び該処理剤系で表面処理された粉体、並びに該粉体を含有する化粧料
US20070093619A1 (en) * 2005-10-24 2007-04-26 L'oreal Compositions having enhanced cosmetic properties
JP5240967B2 (ja) * 2006-02-20 2013-07-17 株式会社 資生堂 油中水型乳化日焼け止め化粧料
US20070243143A1 (en) 2006-04-14 2007-10-18 Patil Anjali A Cosmetic Compositions With Backbiting Silicone Polymers
JP2008050271A (ja) * 2006-08-22 2008-03-06 Shiseido Co Ltd メーキャップ化粧料
JP4059284B1 (ja) 2006-09-29 2008-03-12 富士ゼロックス株式会社 画像形成装置、検査システムおよび検査プログラム
TW200820989A (en) * 2006-09-29 2008-05-16 Shiseido Co Ltd Toner and skin cleanser
US20080292560A1 (en) 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US20080233075A1 (en) 2007-03-22 2008-09-25 Marina Sokolinsky Cosmetic composition for skin tightening
KR101342071B1 (ko) 2007-03-23 2013-12-16 주식회사 엘지생활건강 유성타입의 고형 화장료 조성물
JP2008247757A (ja) 2007-03-29 2008-10-16 Kose Corp 複合粉体及び該複合粉体を含有する化粧料
JP2008255013A (ja) 2007-03-30 2008-10-23 Kose Corp 油性化粧料
FR2918272B1 (fr) 2007-07-03 2010-09-24 Oreal Composition cosmetique associant un polymere silicone, une resine tackifiante, et au moins une resine siliconnee
WO2009016555A2 (en) * 2007-07-27 2009-02-05 The Procter & Gamble Company Conditioning composition comprising dual cationic surfactant system, aminosilicone and silicone resin
CN101424041B (zh) 2007-10-30 2011-07-13 河南瑞贝卡发制品股份有限公司 一种离体发曲发后整理助剂的制备方法
KR20090056301A (ko) 2007-11-30 2009-06-03 (주)아모레퍼시픽 고보습용 화장료 조성물
JP5253826B2 (ja) 2008-01-18 2013-07-31 株式会社ナリス化粧品 マスカラ組成物
FR2927805B1 (fr) 2008-02-26 2011-01-07 Oreal Composition cosmetique comprenant un copolymere silicone particulier, un solvant volatil et une resine de silicone particuliere.
JP5497314B2 (ja) 2008-03-27 2014-05-21 株式会社コーセー 油性化粧料
US20100080768A1 (en) 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
FR2939033B1 (fr) 2008-12-02 2012-08-31 Oreal Composition cosmetique de maquillage et/ou de soin des matieres keratiniques, et procede de maquillage
JP2010144025A (ja) 2008-12-18 2010-07-01 Soft99 Corporation 洗浄艶出し剤
JP4902752B2 (ja) * 2009-01-27 2012-03-21 株式会社 資生堂 油中水型乳化日焼け止め化粧料
JP5572320B2 (ja) 2009-02-12 2014-08-13 花王株式会社 粉末含有油中水型乳化化粧料
BRPI1008384A2 (pt) * 2009-02-20 2017-02-21 Dsm Ip Assets Bv composição que compreende n2-(1-oxohexadecil)-lisil-valil-lisina para tratamento de rosácea e seus sintomas
JP2011001295A (ja) 2009-06-18 2011-01-06 Shiseido Co Ltd 油中水型乳化組成物
JP5667383B2 (ja) 2009-06-19 2015-02-12 花王株式会社 油中水型乳化化粧料
FR2946876B1 (fr) 2009-06-19 2011-07-29 Oreal Composition cosmetique de maquillage et/ou de soin comprenant une resine tackifiante, et une association d'huiles particulieres
FR2947175B1 (fr) 2009-06-25 2011-07-29 Oreal Composition cosmetique comprenant un copolymere styrene/acrylate et une resine siliconee
FR2954157B1 (fr) 2009-12-21 2012-01-13 Oreal Procede de maquillage de la peau et/ou des levres
BR112012023150A2 (pt) * 2010-03-24 2018-06-26 Shiseido Co Ltd produto cosmético de filtro solar.
FR2958544B1 (fr) * 2010-04-12 2012-05-04 Oreal Composition cosmetique comprenant un melange silicone dimethiconol/resine silicone, un solvant volatil une silicone aminee, un pigment, et procede de coloration
US20130046028A1 (en) 2010-04-29 2013-02-21 Dow Corning Toray Co., Ltd. Cosmetic Raw Material
FR2959932A1 (fr) 2010-05-17 2011-11-18 Oreal Composition de maquillage et/ou de soin des fibres keratiniques presentant des proprietes de tenue ameliorees
FR2960433B1 (fr) 2010-05-26 2012-08-17 Oreal Procede cosmetique de maquillage et/ou de soin de la peau et/ou des levres
JP2012041322A (ja) * 2010-08-23 2012-03-01 Shiseido Co Ltd 油中水型乳化化粧料
JP5833812B2 (ja) * 2010-08-27 2015-12-16 株式会社日本色材工業研究所 油性化粧料
JP5679421B2 (ja) 2010-10-05 2015-03-04 株式会社トキワ 棒状化粧料
DE102010063060A1 (de) 2010-12-14 2012-06-14 Henkel Ag & Co. Kgaa Wirkstoffkombination und Haarbehandlungsmittel mit Repair-Effekt
JP2012214453A (ja) 2011-03-31 2012-11-08 Kose Corp 睫用化粧料
US20130028955A1 (en) 2011-07-25 2013-01-31 Gaurav Thakersi Tolia Sustained release oral matrix and methods of making thereof
BR112014016245A8 (pt) 2011-12-30 2017-07-04 Oreal composição e método de maquiar lábios e a pele
US9585831B2 (en) * 2012-12-24 2017-03-07 Conopco, Inc. Cosmetic composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074652A (en) * 1996-05-20 2000-06-13 Shiseido Co., Ltd. Oil-in-water emulsified composition and oil-in-water emulsifying agent
US20120121673A1 (en) * 2009-05-04 2012-05-17 Milanka Susak Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound
US20140213750A1 (en) * 2011-09-07 2014-07-31 Dow Corning Corporation Hafnium Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts
US20130295028A1 (en) * 2012-05-03 2013-11-07 Wilson A. Lee Emulsified MQ Resin: Compositions And Methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COSMETICS BUSINESS ( https://www.cosmeticsbusiness.com/news/article_page/Silicone__smooth_operators/58915 (2011)) *
COUTEAU et al (Mineral filters in sunscreen products – comparison of the efficacy of zinc oxide and titanium dioxide by in vitro method. Pharmazie 63: 58–60 (2008)). *
COUTEAU Mineral filters in sunscreen products comparison of the efficacy of zinc oxide and titanium dioxide by in vitro method. Pharmazie 63 5860 (2008) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11737958B2 (en) 2017-04-18 2023-08-29 Kao Corporation Method for producing UV protective coating

Also Published As

Publication number Publication date
MX2015008283A (es) 2015-12-03
EP2934434A1 (en) 2015-10-28
JP2016503038A (ja) 2016-02-01
WO2014101699A1 (en) 2014-07-03
CA2896264A1 (en) 2014-07-03
MX350296B (es) 2017-09-04
EP2934435A4 (en) 2015-11-11
CA2892740A1 (en) 2014-07-03
EP2953604B1 (en) 2022-06-22
BR112015014497A2 (pt) 2017-07-11
EP2953604A4 (en) 2016-01-20
EP2934435A1 (en) 2015-10-28
ZA201504119B (en) 2016-11-30
CA2896264C (en) 2021-06-08
WO2014101701A1 (en) 2014-07-03
ZA201504557B (en) 2016-11-30
EP2934434B1 (en) 2022-06-29
CA2893456A1 (en) 2014-07-03
JP2016503037A (ja) 2016-02-01
JP2016503039A (ja) 2016-02-01
JP6506696B2 (ja) 2019-04-24
MX2015008296A (es) 2015-09-29
EP2953605A1 (en) 2015-12-16
JP6506695B2 (ja) 2019-04-24
CA2893456C (en) 2020-11-17
MX367560B (es) 2019-08-27
US20150342855A1 (en) 2015-12-03
CA2892740C (en) 2023-07-11
EP2953605A4 (en) 2016-03-02
US20150335569A1 (en) 2015-11-26
EP2934435B1 (en) 2022-06-22
BR112015015123A2 (pt) 2017-07-11
US9585831B2 (en) 2017-03-07
MX367561B (es) 2019-08-27
EP2953604A1 (en) 2015-12-16
JP6496247B2 (ja) 2019-04-03
MX2015008295A (es) 2015-09-29
WO2014101702A1 (en) 2014-07-03
EP2934434A4 (en) 2015-11-18
US10449138B2 (en) 2019-10-22
WO2014101698A1 (en) 2014-07-03
ZA201504118B (en) 2016-11-30

Similar Documents

Publication Publication Date Title
US10449138B2 (en) Cosmetic composition
EP2906184B1 (en) Cosmetic composition
US8105617B2 (en) Cationic copolymers formulated with pigmented cosmetic compositions exhibiting radiance with soft focus
EP2934475B1 (en) Cosmetic composition
CN105246454B (zh) 化妆品组合物
CN104853717B (zh) 化妆品组合物
EP2934433B1 (en) Cosmetic composition
WO2013072200A2 (en) Cosmetic composition
CN104853716B (zh) 化妆品组合物
CN104853739A (zh) 化妆品组合物

Legal Events

Date Code Title Description
AS Assignment

Owner name: CONOPCO, INC., D/B/A UNILEVER, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AO, MINGQI;GHATLIA, NARESH DHIRAJLAL;LI, HANGSHENG;AND OTHERS;SIGNING DATES FROM 20140311 TO 20140312;REEL/FRAME:035984/0418

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION